Dr Lal PathLabs reported a strong financial performance for the second quarter, with net profit rising by 18.9 per cent year-on-year (YoY) to Rs 130.8 crore, up from Rs 110 crore in the same period last year. The company's revenue saw a healthy increase of 9.8 per cent, reaching Rs 660.2 crore compared to Rs 601.3 crore YoY, driven by higher diagnostic volumes.
The company’s EBITDA also grew by 13.9%, totalling Rs 202.5 cr, while the EBITDA margin improved to 30.7% from 29.6% YoY.
This solid performance reflects efficient cost management and enhanced operational efficiency during the quarter.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Senior Citizen Latest FD Rates: Know what major banks like SBI, PNB, Canara Bank, HDFC Bank, ICICI Bank are providing on fixed deposits
Gratuity Calculator: Rs 38,000 as last-drawn basic salary, 5 years and 5 months of service; what will be gratuity amount?
Top 5 Small Cap Mutual Funds with best SIP returns in 1 year: See how Rs 25,000 monthly investment has grown in each scheme
Top 7 SBI Mutual Funds With Best SIP Returns in 1 Year: Rs 25,000 monthly SIP investment in No.1 fund has jumped to Rs 3,58,404
SBI 5-Year FD vs MIS: Which can offer higher returns on a Rs 2,00,000 investment over 5 years? See calculations
04:45 PM IST